Heart Failure Probability and Early Outcomes of Critically Ill Patients With COVID-19: A Prospective, Multicenter Study

Frontiers in Cardiovascular Medicine - Tập 8
Weibo Gao1, Jiasai Fan2, Di Sun2, Mengxi Yang2, Wei Guo3, Liyuan Tao4, Jingang Zheng2, Jihong Zhu1, Tianbing Wang3, Jingyi Ren2
1Department of Emergency, Peking University People’s Hospital, Beijing, China
2Department of Cardiology, Heart Failure Center, China-Japan Friendship Hospital, Beijing, China
3Trauma Center, Peking University People’s Hospital, Beijing, China
4Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China

Tóm tắt

Background: The relationship between cardiac functions and the fatal outcome of coronavirus disease 2019 (COVID-19) is still largely underestimated. We aim to explore the role of heart failure (HF) and NT-proBNP in the prognosis of critically ill patients with COVID-19 and construct an easy-to-use predictive model using machine learning.Methods: In this multicenter and prospective study, a total of 1,050 patients with clinical suspicion of COVID-19 were consecutively screened. Finally, 402 laboratory-confirmed critically ill patients with COVID-19 were enrolled. A “triple cut-point” strategy of NT-proBNP was applied to assess the probability of HF. The primary outcome was 30-day all-cause in-hospital death. Prognostic risk factors were analyzed using the least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression, further formulating a nomogram to predict mortality.Results: Within a 30-day follow-up, 27.4% of the 402 patients died. The mortality rate of patients with HF likely was significantly higher than that of the patient with gray zone and HF unlikely (40.8% vs. 25 and 16.5%, respectively, P < 0.001). HF likely [Odds ratio (OR) 1.97, 95% CI 1.13–3.42], age (OR 1.04, 95% CI 1.02–1.06), lymphocyte (OR 0.36, 95% CI 0.19–0.68), albumin (OR 0.92, 95% CI 0.87–0.96), and total bilirubin (OR 1.02, 95% CI 1–1.04) were independently associated with the prognosis of critically ill patients with COVID-19. Moreover, a nomogram was developed by bootstrap validation, and C-index was 0.8 (95% CI 0.74–0.86).Conclusions: This study established a novel nomogram to predict the 30-day all-cause mortality of critically ill patients with COVID-19, highlighting the predominant role of the “triple cut-point” strategy of NT-proBNP, which could assist in risk stratification and improve clinical sequelae.

Từ khóa


Tài liệu tham khảo

Grasselli, 2020, Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy, JAMA., 323, 1574, 10.1001/jama.2020.5394

Arentz, 2020, Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state, JAMA., 323, 1612, 10.1001/jama.2020.4326

Casadevall, 2020, A Randomized trial of convalescent plasma for COVID-19—potentially hopeful signals, JAMA., 324, 455, 10.1001/jama.2020.10218

Wang, 2020, Comorbidities and multi-organ injuries in the treatment of COVID-19, Lancet., 395, e52, 10.1016/S0140-6736(20)30558-4

Aboughdir, 2020, Prognostic value of cardiovascular biomarkers in COVID-19: a review, Viruses., 12, 527, 10.3390/v12050527

Mueller, 2019, Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations, Eur J Heart Fail., 21, 715, 10.1002/ejhf.1494

Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med., 8, 475, 10.1016/S2213-2600(20)30079-5

Yu, 2020, Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study, Crit Care., 24, 219, 10.1186/s13054-020-02939-x

Haase, 2021, Characteristics, interventions, and longer term outcomes of COVID-19 ICU patients in Denmark—a nationwide, observational study, Acta Anaesthesiol Scand., 65, 68, 10.1111/aas.13701

2020, Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (nCoV) Infection Is Suspected: Interim Guidance, 25 January 2020

Xie, 2020, Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study, Intensive CareMed., 46, 1863, 10.1007/s00134-020-06211-2

Feng, 2020, Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics, Nat Commun., 11, 4968, 10.1038/s41467-020-18786-x

Wynants, 2020, Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal, BMJ., 369, m1328, 10.1136/bmj.m1328

Vultaggio, 2020, Prompt predicting of early clinical deterioration of moderate-to-severe COVID-19 patients: usefulness of a combined score using IL-6 in a preliminary study, J Allergy Clin Immunol Pract., 8, 2575, 10.1016/j.jaip.2020.06.013

Inciardi, 2020, Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy, Eur Heart J., 41, 1821, 10.1093/eurheartj/ehaa388

Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China, JAMA., 323, 1061, 10.1001/jama.2020.1585

Liu, 2020, The science underlying COVID-19: implications for the cardiovascular system, Circulation., 142, 68, 10.1161/CIRCULATIONAHA.120.047549

Zhang, 2020, Development and validation of a risk factor-based system to predict short-term survival in adult hospitalized patients with COVID-19: a multicenter, retrospective, cohort study, Crit Care., 24, 438, 10.1186/s13054-020-03123-x

Ibrahim, 2020, Natriuretic peptides as inclusion criteria in clinical trials, JACC Heart Fail., 8, 347, 10.1016/j.jchf.2019.12.010

Gao, 2020, Prognostic value of NT-proBNP in patients with severe COVID-19, Respir Res., 21, 83, 10.1186/s12931-020-01352-w

Pranata, 2020, Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis, Postgrad Med J., 96, 387, 10.1136/postgradmedj-2020-137884

Sorrentino, 2020, B-type natriuretic peptide as biomarker of COVID-19 disease severity—a meta-analysis, J Clin Med., 9, 2957, 10.3390/jcm9092957

Shi, 2020, Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China, JAMA Cardiol., 5, 802, 10.1001/jamacardio.2020.0950

Caro-Codón, 2021, Characterization of NT-proBNP in a large cohort of COVID-19 patients, Eur J Heart Fail, 23, 456, 10.1002/ejhf.2095

Guo, 2020, Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19), JAMA Cardiol., 5, 811, 10.1001/jamacardio.2020.1017

Dong, 2020, Development and validation of a nomogram for assessing survival in patients with COVID-19 pneumonia, Clin Infect Dis., 72, 652, 10.1093/cid/ciaa963

Bloom, 2021, Liver biochemistries in hospitalized patients with COVID-19, Hepatology., 73, 890, 10.1002/hep.31326

Suzuki, 2020, Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction, Eur J Heart Fail., 22, 1662, 10.1002/ejhf.1853

Gupta, 2020, Factors associated with death in critically ill patients with coronavirus disease 2019 in the US, JAMA Intern Med., 180, 1, 10.1001/jamainternmed.2020.3596

Thông tin
Thông tin xuất bản

Frontiers in Cardiovascular Medicine

Tập 8

Thông tin tác giả